Fibrogen Inc CS (FGEN)

$1.24 0.05 (4.20%)

16:15 EDT FGEN Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

By William White, InvestorPlace Writer May 7, 2024

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Tuesday!

FGEN Stock Earnings: FibroGen Beats EPS, Beats Revenue for Q1 2024

3 Nightmare Nasdaq Stocks Not Worth Holding Another Day

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Volume:

Previous Close -

Market Cap 121.78M

PE Ratio -1.38

EPS -0.9

Volume (Avg. Vol.) 1.66M

Day's Range $1.13 - $1.26

52-Week Range $0.33 - $17.89

Dividend & Yield N/A (N/A)

FGEN Stock Predictions, Articles, and Fibrogen Inc CS News

From InvestorPlace
From the Web

7 Stocks to Sell Before the Axe Falls

By Josh Enomoto, InvestorPlace Contributor Oct 19, 2023

While an uncomfortable topic to discuss, consistent success in the market will require an objective view of stocks to sell.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Aug 30, 2023

Pre-market stock movers are a hot topic on Wednesday morning and we're covering the shares rising and falling this morning!

Why Is FibroGen (FGEN) Stock Down 81% Today?

By William White, InvestorPlace Writer Jun 26, 2023

FibroGen (FGEN) stock is heading lower on Monday after the company's Phase 3 clinical trial failed to meet its primary endpoint.

7 Unknown Biotech Stocks That Could Rocket in 2023

By Faisal Humayun, InvestorPlace Contributor Sep 23, 2022

Unknown biotech stocks that are poised for a big rally in 2023. Emerging biotech companies with a promising clinical pipeline.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer May 9, 2022

Good morning, trader! We're starting off another week of trading with an overview of the biggest pre-market stock mover for Monday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jul 16, 2021

It's been a busy week of trading but it's almost over. Join me as we start Friday with a look at the biggest pre-market stock movers!

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Wednesday Morning

By William White, InvestorPlace Writer Apr 7, 2021

We're only halfway through the week but there's plenty of pre-market movers that investors will want to keep an eye on today.

7 Big Biotech Stocks to Avoid

By Louis Navellier, Editor, Growth Investor Jan 28, 2020

The only thing more important than what to buy is what not to buy. These biotech stocks are at the top of the avoid list. Here's why.

FibroGen News: Why FGEN Stock Is Plummeting Today

By William White, InvestorPlace Writer May 10, 2019

FibroGen news has FGEN stock down on Friday after releasing confusing results from a recent trial for its kidney disease drug.

Mizuho: 7 Long-Term Value Stocks to Buy Now

By Harriet Lefton, Writer, TipRanks Jan 14, 2019

Mizuho Securities has challenged each analyst to select long-term stocks that can provide value. Here are 7 of their top stock picks.

AstraZeneca returns right to roxadustat to FibroGen (NASDAQ:FGEN)

From Seeking Alpha Feb 26, 2024

AstraZeneca returns rights to FibroGen for roxadustat, a drug used for treating anemia related to chronic kidney disease. Read more here.

FibroGen names Thane Wettig as permanent CEO (NASDAQ:FGEN)

From Seeking Alpha Oct 6, 2023

FibroGen appoints Thane Wettig as permanent CEO, elevating him from interim CEO, following the departure of former CEO Enrique Conterno. Read more here.

FibroGen stock tumbles on failed Phase 3 study for muscular dystrophy drug (NASDAQ:FGEN)

From Seeking Alpha Aug 29, 2023

FibroGen (FGEN) stock tumbled Tuesday evening after it reported that a Phase 3 study for its drug pamrevlumab for DMD failed to meet its primary endpoint. Read more here.

BofA downgrades FibroGen to underperform, cites unfavorable catalysts (NASDAQ:FGEN)

From Seeking Alpha Aug 8, 2023

BofA Securities has downgraded FibroGen to underperform, citing an "unfavorable catalyst pathway" and the expected loss of Chinese market exclusivity for its drug roxadustat.

Down 80% in 1 Day, Is There Any Hope for FibroGen Stock?

From The Motley Fool Jul 1, 2023

Its pipeline is looking thin, and it might hit another speed bump quite soon.

FibroGen gets an interim CEO (NASDAQ:FGEN)

From Seeking Alpha Jul 25, 2023

FibroGen (FGEN) appoints Thane Wettig as the company’s interim CEO effective as of July 23, 2023. Mr

Fibrogen Inc CS (FGEN)

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

FGEN Stock Earnings: FibroGen Beats EPS, Beats Revenue for Q1 2024

3 Nightmare Nasdaq Stocks Not Worth Holding Another Day

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Fibrogen Inc CS (FGEN)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

FGEN Stock Predictions, Articles, and Fibrogen Inc CS News

Subscriber Sign in